Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05475_nanopub.RAcFWYWDFObbZh2wvv1m49jdtKDonYXg-4IjuOV4NskYk#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05475 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05475 label "SCV-07 [drugbank:DB05475]" assertion.
- drugbank:DB05475 seeAlso DB05475 assertion.
- drugbank:DB05475 description "SCV-07 (g -D-glutamyl-L-tryptophan) is a novel synthetic dipeptide that acts broadly on the Toll-like receptor pathway. It has been shown to stimulate T-lymphocyte differentiation, macrocytic phagocytosis, and specific immune responses, and enhance IL-2 and INF-g production. Due to this preferential activation of Th1 cytokine production, SCV-07 may show utility in treatment of tuberculosis. It can be administered orally or subcutaneously. In independent studies, treatment of tuberculosis with SCV-07 improved clearance of mycobacteria, improved cavity healing, improvements in immune parameters and reduced symptoms (fever, weakness, sweating, dry cough, productive cough, dyspnea, chest pain, tachycardia) without any adverse local or general effects. SCV-07 has shown efficacy in treating various viral and bacterial infections." assertion.
- drugbank:DB05475 identifier "drugbank:DB05475" assertion.
- drugbank:DB05475 title "SCV-07" assertion.
- drugbank:DB05475 drugbank_vocabulary:x-pubchemcompound pubchem.compound:6992140 assertion.
- drugbank:DB05475 drugbank_vocabulary:x-chemspider chemspider:5360288 assertion.
- drugbank:DB05475 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05475 drugbank_vocabulary:drugbank-id "DB05475" assertion.
- drugbank:DB05475 bio2rdf_vocabulary:x-identifiers.org DB05475 assertion.
- drugbank:DB05475 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05475" assertion.
- drugbank:DB05475 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05475 bio2rdf_vocabulary:identifier "DB05475" assertion.